Overview

CsA vs MMC for Preventing Pterygium Recurrence

Status:
COMPLETED

Trial end date:
2024-10-15

Target enrollment:

Participant gender:

Summary

aimed to compare the efficacy and safety of topical cyclosporin A (CsA) versus mitomycin C (MMC) as adjunctive therapies in preventing pterygium recurrence after surgical excision.

Phase:

Details

Lead Sponsor:

Benha University